- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
What Do I Specialise In?
Dr Tom Newsom-Davis a Medical Oncologist who specialises in the treatment of lung cancers. This includes non-small cell lung cancer (adenocarcinoma, squamous cell carcinoma), small cell carcinoma, pleural mesothelioma, and thymic tumours (thymoma, thymic carcinoma). He has a particular expertise in non-smoking lung cancers such as EGFR, ALK, ROS1 and RET.
Dr Newsom-Davis specialises in treatments such as immunotherapy, targeted (biological) therapies, and chemotherapy.
Where Do I Work?
Dr Newsom-Davis has been a consultant at Chelsea and Westminster NHS Hospital since 2010, where he leads the lung cancer unit. He is also an Honorary Consultant at the Royal Brompton Hospital, London.
Dr Newsom-Davis sees private patients at LOC Chelsea (102 Sydney Street, London) and LOC Harley Street (95 Harley Street, London).
What Is My Background?
Dr Newsom-Davis completed his training at University College and Middlesex School of Medicine, London, in 1998, including First Class honours for his BSc. He went on specialise in medical oncology at Charing Cross and Hammersmith Hospitals, and completed a PhD in tumour immunology.
What Are My Current Roles?
Dr Newsom-Davis is the Chair of the British Thoracic Oncology Group (BTOG) Steering Committee, the national organistion supporting and educating thoracic oncology professionals across the United Kingdom. Dr Newsom-Davis sits on the Oncology Council for the Royal Society of Medicine (RSM) and is a Committee member for the International Association for the Study of Lung Cancer (IASLC).
Dr Newsom-Davis serves as a expert clinical advisor for bodies including NICE, Roy Castle Lung Cancer Foundation, and ALK+ UK.
What Research Do I Do?:
Dr Newsom-Davis has an active clinical trial portfolio, including being the national lead for several studies, and has presented his work at National and International meetings. He has been an invited lecturer for organisations including the Royal College of Physicians, European Society of Medical Oncology, International Association for the Study of Lung Cancer, British Medical Association and the Association of Cancer Physicians.
Areas of interest
Adults; Lung cancer; Non-small cell lung cancer; Small cell lung cancer; Mesothelioma; Thymoma; Thymic Carcinoma; Immunotherapy ; Targeted Therapies; Chemotherapy
Medical secretaries
- Rubi Solic
- LOC: Leaders in Oncology Care 95 Harley Street LONDON W1G 6AF
- 020 7317 2662
- 020 7009 4262
- newsom-davispa@hcahealthcare.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
HCA Healthcare UK Sydney Street Outpatients (5-50) HCA Healthcare UK Leaders in Oncology Care (1-5)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)
Launch
Website



